Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Walgreens maintains full-year profit growth forecast; shares rise

Stock MarketsJan 07, 2021 12:35PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. A sign rests on a counter at a Walgreens pharmacy store in Austin, Texas 2/2

By Mrinalika Roy and Dania Nadeem

(Reuters) - Walgreens Boots Alliance (NASDAQ:WBA) Inc said on Thursday it expects benefits from COVID-19 vaccinations to cushion the impact of pandemic-induced restrictions, and stuck to its full-year earnings growth forecast, sending its shares up 7%.

The drugstore chain has taken a number of steps to bolster profit after the health crisis hammered sales and forced it to cut jobs, shut some UK-based Boots stores and sell its distribution unit to AmerisourceBergen (NYSE:ABC) Corp for $6.5 billion.

Rival CVS Health Corp (NYSE:CVS) and Walgreens have an agreement with the federal government to vaccinate nursing home residents across the United States through a voluntary program.

Walgreens said it expects to see some benefit from COVID-19 vaccinations in the second half of fiscal 2021.

"The administration of vaccinations to care homes is not a particularly profitable business," Chief Executive Officer Stephano Pessina said.

"That being said, the vaccines will be accretive to the profile in the second half of the year. And that's why... we did change the tone of our guidance."

Walgreens maintained fiscal 2021 forecast of low single-digit growth in adjusted EPS, after it beat analysts' estimates for adjusted first-quarter profit.

Same-store sales in Boots UK pharmacies rose 2.5% in the quarter, while Boots.com saw a 106% sales growth.

Walgreens expects significant growth in its UK business in the second half of the year from cost cuts. The company, however, cautioned that the lockdown in the UK could hurt its business.

"The big negative and the big question mark, and it's the reason why we basically maintain guidance is, we actually have a lockdown in the U.K. right now that runs through the middle of February," Chief Financial Officer James Kehoe said.

Walgreens maintains full-year profit growth forecast; shares rise
 

Related Articles

3 Stocks Rated 'Strong Sell' to Avoid at All Costs
3 Stocks Rated 'Strong Sell' to Avoid at All Costs By StockNews - Oct 18, 2021

Even though the market indexes rallied last week on a stellar start to the third-quarter earnings season, inflation and supply chain concerns are worrying investors. So, we think...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email